BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Debiopharm at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Debiopharm takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions ask where investors, pharma and biotech are placing their bets on the next oncology winners, and introduce Debiopharm to dealmakers in the Business of Biotech track. Debiopharm also sponsors the meeting.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Debiopharm Lausanne, Switzerland | ◆Gold Sponsor |
Swiss privately owned biopharmaceutical group developing oncology and bacterial infection treatments. | Panel Mon Nov 9 15:00–15:45 The next oncology winners: Where investors, pharma and biotech are placing their bets Which cancer treatments, from radioactive targeted drugs to newer immunotherapies, now draw investors, and what makes a cancer biotech worth funding. Talk Tue Nov 10 10:15–10:30 Pharma Presentation: Debiopharm International SA How Debiopharm licenses in promising drugs for cancer and bacterial infections, tests them in trials, then picks large drug companies to sell them. |
Find decision makers at Debiopharm
Tell us what you sell and we’ll find the people at Debiopharm most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction